ROI Financial Advisors LLC Trims Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• ROI Financial Advisors LLC reduced its holdings in UnitedHealth Group by 23.5% during the 1st quarter, now owning 3,850 shares valued at approximately $2,016,000.
• The company recently missed earnings estimates, reporting $4.08 earnings per share compared to the consensus estimate of $4.45, while revenue was slightly below expectations at $111.62 billion.
• UnitedHealth Group declared a quarterly dividend of $2.21 per share, up from the previous dividend of $2.10, marking an annualized yield of 3.7%.

ROI Financial Advisors LLC lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 23.5% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 3,850 shares of the healthcare conglomerate's stock after selling 1,181 shares during the period. UnitedHealth Group comprises 1.5% of ROI Financial Advisors LLC's holdings, making the stock its 19th largest holding. ROI Financial Advisors LLC's holdings in UnitedHealth Group were worth $2,016,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of UNH. Financial Management Professionals Inc. increased its position in UnitedHealth Group by 0.8% during the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after buying an additional 17 shares during the last quarter. Global Wealth Strategies & Associates increased its stake in UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after acquiring an additional 20 shares during the period. Kolinsky Wealth Management LLC raised its stake in shares of UnitedHealth Group by 1.0% in the 4th quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock valued at $1,080,000 after buying an additional 21 shares in the last quarter. Retirement Planning Group LLC raised its stake in shares of UnitedHealth Group by 5.1% in the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock valued at $225,000 after acquiring an additional 21 shares during the last quarter. Finally, Net Worth Advisory Group raised its position in UnitedHealth Group by 0.6% in the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock worth $1,907,000 after purchasing an additional 21 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Down 1.3%

NYSE:UNH traded down $3.10 during mid-day trading on Thursday, reaching $242.68. 6,587,627 shares of the company's stock traded hands, compared to its average volume of 12,083,630. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The company has a 50 day moving average price of $293.86 and a 200-day moving average price of $410.54. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a market capitalization of $220.15 billion, a price-to-earnings ratio of 10.53, a PEG ratio of 1.62 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.80 earnings per share. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.6%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio is currently 38.30%.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. TD Securities reaffirmed a "hold" rating and issued a $308.00 price target (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Baird R W downgraded UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research note on Thursday, July 31st. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. JPMorgan Chase & Co. cut their price target on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a research note on Wednesday. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $366.52.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CFO John F. Rex purchased 17,175 shares of the stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer owned 203,796 shares in the company, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Kristen Gil acquired 3,700 shares of the company's stock in a transaction on Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the acquisition, the director directly owned 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.